Text Size
38 studies found for:    Open Studies | "Arthritis, Juvenile Rheumatoid"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Arthritis, Juvenile Rheumatoid"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention:
2 Recruiting Juvenile Idiopathic Arthritis (JIA) Registry
Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: adalimumab;   Drug: Methotrexate
3 Not yet recruiting Cost of Care for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
4 Not yet recruiting Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
5 Recruiting Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Conditions: Uveitis;   Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody;   Drug: placebo
6 Not yet recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
7 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
8 Unknown † The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
Conditions: Uveitis;   Arthritis, Juvenile Rheumatoid
Intervention: Drug: TNFR:Fc
9 Unknown † Jointstrong Intervention for Juvenile Arthritis
Condition: Juvenile Arthritis
Interventions: Behavioral: CD-ROM;   Behavioral: Wait-list Control Group
10 Unknown † Juvenile Rheumatoid Arthritis Research Registry
Condition: Juvenile Rheumatoid Arthritis
Intervention:
11 Recruiting Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Behavioral: comparison of types of sleep disordered breathing
12 Recruiting An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
13 Recruiting Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: etanercept
14 Recruiting Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: Web-based coping skills training;   Behavioral: Online disease education
15 Recruiting Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: 800 mg ibuprofen/26.6 mg famotidine
16 Unknown † Magnetic Resonance Imaging Follow-up on Temporomandibular Arthritis in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Procedure: Steroid injection into the TMJs.
17 Recruiting Long-Term Safety Study Of CP-690,550 In Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
18 Recruiting An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: RoActemra/Actemra (tocilizumab)
19 Not yet recruiting A Study of Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra]
20 Recruiting Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: CP-690,550
To Top

Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results
† Indicates status has not been verified in more than two years